William Rastetter

Founder of Receptos LLC, Apoptos, Inc. and GRAIL, Inc., William H. Rastetter is an entrepreneur and businessperson who has been at the head of 13 different companies and occupies the position of Chairman of Neurocrine Biosciences, Inc., Chairman for Fate Therapeutics, Inc. and Chairman for Daré Bioscience, Inc. Dr. Rastetter is also on the board of California Institute of Technology, CONNECT, Regulus Therapeutics, Inc. (former Chairman) and GRAIL, Inc. (former Chairman). In his past career Dr. Rastetter was Executive Chairman for Biogen, Inc. Chairman & Chief Executive Officer at IDEC Pharmaceuticals Corp. and Executive Chairman for Biogen Idec, Inc. (North Carolina) (both are subsidiaries of Biogen, Inc.), Chairman of Illumina, Inc., Partner at Venrock Associates, Chairman & Chief Executive Officer for Celgene Corp., Chairman & Chief Executive Officer at Apoptos, Inc., Executive Chairman at Receptos LLC, Chairman for Cerulean Pharma, Inc., Director-Corporate Ventures at Genentech, Inc., Faculty Member at Harvard University and Associate Professor at Massachusetts Institute of Technology. He received a doctorate and a graduate degree from Harvard University and an undergraduate degree from Massachusetts Institute of Technology.